Here, we reported that, among the members of type I PRMT family, levels of PRMT1, PRMT4, and PRMT6 were elevated in NSCLC, and high expression was associated with poorer patient survival. This evidence concerns the gene PRMT6 and non-small cell lung carcinoma.